1. France Stocks

  2. •

    Consumer non-durables

  3. •

    Food: specialty/candy
Fermentalg SA

Fermentalg SA

0.37
EUR
-0.01
(-1.60%)
40.92MMarket Cap
Apr 16Next Earn
Fermentalg SA
LSE:0QTJ
(London Stock Exchange)

Recent

price

0.37

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
EUR
0.02
0.02
0.02
0.09
0.04
0.01
0.01
0.01
0.11
0.1
0.16
0.18
0.09
0.15
0.13
- -
Revenue per Share
-0.12
-0.3
-0.23
-0.4
-0.42
-0.63
-0.56
-0.47
-0.97
-0.32
-0.19
-0.24
-0.32
-0.17
-0.09
- -
Basic EPS, GAAP
-0.36
-0.36
-0.99
-0.65
-1.14
-1.06
-0.83
-0.53
-0.56
-0.57
-0.33
-0.32
-0.25
-0.03
-0.08
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.8
0.57
1.93
3.99
3.56
2.94
2.41
2.01
0.9
0.8
1.18
1
0.6
0.36
0.26
0.26
Book Value per Share
0.8
0.43
1.68
3.74
3.22
2.46
1.94
1.37
0.49
0.41
0.86
0.66
0.31
0.2
0.11
0.11
Tangible Book Value per Share
8
8
8
10
12
12
13
17
18
22
36
41
44
74
105
98
Basic Weighted Avg Shares
- -
- -
- -
1
- -
- -
- -
- -
2
2
6
8
4
11
13
- -
Sales/Revenue/Turnover
-1,207.86
-2,004.35
-1,513.81
-441.78
-1,207.72
-4,456.93
-4,270
-3,037.4
-479.61
-403.54
-150.17
-115.94
-272.94
-80.47
-70.11
- -
Operating Margin (%)
- -
- -
1
1
1
2
2
3
7
1
1
3
3
3
3
- -
Depreciation Expense
-1
-2
-2
-4
-5
-8
-7
-8
-17
-7
-7
-10
-14
-13
-9
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-661.43
-1,670.29
-969.61
-449.89
-1,103.97
-5,517.52
-4,275.88
-3,289.02
-916.05
-311.93
-121.3
-129.11
-348.73
-111.99
-70.51
- -
Profit Margin (%)
3
-1
7
40
27
13
21
12
4
8
29
22
17
16
7
7
Working Capital
- -
1
1
2
3
3
8
8
7
11
9
10
14
7
4
4
LT Debt
6
4
15
49
44
37
41
34
19
20
47
42
31
33
25
25
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
-43.77
-18.31
-12.73
-11.35
-18.67
-18.68
-21.43
-65.42
-35.39
-20.35
-22.19
-38.85
-40.49
-32.58
- -
Return on Common Equity (%)

Capital Structure

EUR

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
6
6
1
LT Borrowings
7
4
4
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
90
96
96
Market Capitalization
30
46
41

Working Capital

EUR

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
27
23
13
Cash, Cash Equivalents & STI
21
13
7
Accounts Receivable, Net
3
6
3
Inventories
1
1
1
Total Current Liabilities
11
12
7
Payables & Accruals
- -
- -
- -
ST Debt
6
6
1
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
1.91%
15.47%
-23.14%
Free Cash Flow
20.77%
43.19%
306.05%
Net Income, GAAP
15.53%
10.27%
-26.71%
Sales/Revenue/Turnover
102.6%
68.88%
16.41%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
4
2024
- -
- -
11
2025
- -
- -
13

Semi-annual Earnings Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
-0.32
2024
- -
- -
-0.17
2025
- -
- -
-0.09

Semi-annual Dividends Per Share

EUR

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -
Similar Companies
PepsiCo, Inc. (NASDAQ:PEP)
Britannia Industries Ltd (NSE:BRITANNIA)
Tata Consumer Products Limited (NSE:TATACONSUM)
Ulker Biskuvi Sanayi A.S. (BIST:ULKER)
Mondelez International, Inc. (NASDAQ:MDLZ)
The Hershey Company (NYSE:HSY)
Business
Fermentalg is a biotechnology company specialized in the development and production of natural microalgae-based products. The company manufactures and sells a broad range of solutions including microalgae biomass, oils, proteins, and nutritional ingredients targeting sectors such as human nutrition, animal feed, aquaculture, cosmetics, and bioactive compounds. Its product portfolio comprises bioactive molecules for immune health and anti-inflammatory applications; natural pigments like astaxanthin and beta-carotene; omega-3 fatty acids; and tailored microalgae strains for customized applications. Founded in 2009 and headquartered in Libourne, France, Fermentalg operates primarily in Europe with expanding global ambitions. The company focuses on the sustainable production of microalgae through proprietary fermentation and photobioreactor technologies. In the last two years, Fermentalg has pursued strategic developments including new partnerships with industry stakeholders to expand market presence and advance its technology platforms. It also undertook operational enhancements to scale up production capacities and recently launched novel product lines in the nutritional supplement category to diversify its offerings. These initiatives reflect Fermentalg’s commitment to innovation and growth in the bio-based industrial segment. Fermentalg serves diverse markets including food and beverages, dietary supplements, pharmaceuticals, and personal care, positioning itself as a key player in the green biotech and sustainable ingredients industry. It operates through direct sales and collaborations with industrial partners and research institutions to drive product development and commercialization. Overall, Fermentalg integrates pioneering microalgae biotechnology with a strategic focus on market-driven products and scalable production processes, underpinned by its headquarters in France and established since 2009.